CCL5 and atrial fibrillation: In vitro investigation demonstrated the ability of CCL5 to promote AF cell migration, however, no significant AF repair effect was observed in vivo. This suggests that, in addition to chemokines, appropriate scaffolds should also be considered to provide a favorable microenvironment for the recruited cells when designing an endogenous repair strategy.